From: Vahe Stepanian To: Jeffrey Epstein <[email protected]> Stewart Oldfield , Richard Kahn , Ariane Ds er , Paul Morris CC: Daniel Sabba Subject: SGMO and VIAB [C) Date: Thu, 06 Aug 2015 15:57:59 +0000 Inline-Images: image002.jpg; image004.jpg Classification: Confidential Jeffrey — as you may have seen, SGMO and VIAB reported earnings yesterday afternoon and this morning (respectively). Each name is down 17%+ on the back of the reports as both missed analyst expectations. Recall that you're long the following: Ticker SGMO VIAB Thank you, Vahe Quantity 50,000 5,000 Date of Pur Ace Cost Ras' 5/28/2013 $8.44 6/10/2015 $67.74 _SGMO U5 $ S T 7.5899 -1.65 At 11:49 Vol 1,382,929 0 8.57Q 97) Actions • SGMO US E uit Sangamo BioSciences Inc 1) Earnings History (ERN) Next Announcement (E) 10/22/15 Prior Announcement 08/05/15 Avg/Implied 1 Day Move 8.82% / • P7.58/7.59P H 8.609 L 7.39D 98) Output Perioclicit; 2) Current Multiples Trailing 12M P/E Forward 12M P/E Est. LTG (EPS) 4x4 Val 10.817m Earnings & Estimates' Source Standard g Cur USD II 3) Analyst Coverage (ANR) Buy/Hold/Sell 7/0/0 Current Price Target Price 7.55 22.00 Current Consensus (EEO) 2D Current Period Overview (Q3/15) 2D Prior Period Analysis (02/1S) Meastire Estiniate Surprise Comps Scorecard (7 of 15) Past Surprise 11) EPS Adjusted+ -0.170 -0.122 Beat:4 Met:1 Missed:2 Beat 4 of 8 12) EPS GAAP -0.170 -0.115 Beat:4 Met:1 Missed:2 Beat 4 of 8 13) Sales 8.358M 14.600M Beat:4 Met:0 Missed:3 Beat 7 of 8 14) Net Income Adjusted+ -12.126M -8.286M Beat:4 Met:0 Missed:3 Beat 5 of 8 1S) Operating Profit 16) EBITDA S. Earnings Trends (EM) -8.655M -8.000M • Q2s Only ) Estimate Revision Charting (EEG) •MaW AyW **ad r r I rr ,211•14 0.1- 14 C14. 14 01. 15 02 15 03 IS au 01 10 02 10 Ni00 om MW 20M 0.10 MOO MW lW 4212 -014 12M ' 046 IOM o.ta tkco IS OdNolod Swale •12 • Mar 735 EFTA01207022